PEDIATRICS Vol. 123 No. 1 January 2009, pp. 1-5 (doi:10.1542/peds.2008-0200)
ARTICLE |
Prevalence and Time Course of Acute Mountain Sickness in Older Children and Adolescents After Rapid Ascent to 3450 Meters
a Botnar Center for Extreme Medicine, Department of Internal Medicine, University Hospital, Lausanne, Switzerland
b Swiss Cardiovascular Center Bern, University Hospital, Bern, Switzerland
c Institute of Exercise and Health Sciences, University of Basel, Basel, Switzerland
OBJECTIVE. Acute mountain sickness is a frequent and debilitating complication of high-altitude exposure, but there is little information on the prevalence and time course of acute mountain sickness in children and adolescents after rapid ascent by mechanical transportation to 3500 m, an altitude at which major tourist destinations are located throughout the world.
METHODS. We performed serial assessments of acute mountain sickness (Lake Louise scores) in 48 healthy nonacclimatized children and adolescents (mean ± SD age: 13.7 ± 0.3 years; 20 girls and 28 boys), with no previous high-altitude experience, 6, 18, and 42 hours after arrival at the Jungfraujoch high-altitude research station (3450 m), which was reached through a 2.5-hour train ascent.
RESULTS. We found that the overall prevalence of acute mountain sickness during the first 3 days at high altitude was 37.5%. Rates were similar for the 2 genders and decreased progressively during the stay (25% at 6 hours, 21% at 18 hours, and 8% at 42 hours). None of the subjects needed to be evacuated to lower altitude. Five subjects needed symptomatic treatment and responded well.
CONCLUSION. After rapid ascent to high altitude, the prevalence of acute mountain sickness in children and adolescents was relatively low; the clinical manifestations were benign and resolved rapidly. These findings suggest that, for the majority of healthy nonacclimatized children and adolescents, travel to 3500 m is safe and pharmacologic prophylaxis for acute mountain sickness is not needed.
Key Words: acute mountain sickness altitude adolescents prevalence
Abbreviations: AMS—acute mountain sickness
Accepted Apr 4, 2008.
![]()
CiteULike
Connotea
Del.icio.us
Digg
Facebook
Reddit
Technorati
Twitter What's this?
This article has been cited by other articles:
![]() |
E Scrase, A Laverty, J C D Gavlak, S Sonnappa, D Z H Levett, D Martin, M P W Grocott, and J Stocks The Young Everest Study: effects of hypoxia at high altitude on cardiorespiratory function and general well-being in healthy children Arch. Dis. Child., August 1, 2009; 94(8): 621 - 626. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. G. Slomiany, L. Dai, P. A. Bomar, T. J. Knackstedt, D. A. Kranc, L. Tolliver, B. L. Maria, and B. P. Toole Abrogating Drug Resistance in Malignant Peripheral Nerve Sheath Tumors by Disrupting Hyaluronan-CD44 Interactions with Small Hyaluronan Oligosaccharides Cancer Res., June 15, 2009; 69(12): 4992 - 4998. [Abstract] [Full Text] [PDF] |
||||
eLetters:
Read all eLetters
- Personal experience with AMS
- Michael Cater, MD
- Pediatrics Online, 21 Jan 2009 [Full text]






